X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25687) 25687
Publication (3890) 3890
Book Review (303) 303
Book Chapter (156) 156
Conference Proceeding (30) 30
Dissertation (30) 30
Book / eBook (9) 9
Magazine Article (8) 8
Data Set (3) 3
Government Document (3) 3
Paper (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17014) 17014
humans (15697) 15697
oncology (7700) 7700
cancer (7612) 7612
animals (7515) 7515
apoptosis (6790) 6790
cell line, tumor (6361) 6361
cell biology (6194) 6194
cell cycle (5647) 5647
biochemistry & molecular biology (4607) 4607
immunotherapy (4299) 4299
mice (4089) 4089
apoptosis - drug effects (3973) 3973
female (3907) 3907
phosphorylation (3905) 3905
proteins (3667) 3667
dna damage (3627) 3627
expression (3308) 3308
cell cycle checkpoints - drug effects (3270) 3270
cell proliferation - drug effects (3102) 3102
tumors (2973) 2973
research (2872) 2872
article (2681) 2681
immune checkpoint (2674) 2674
checkpoint (2614) 2614
male (2585) 2585
antineoplastic agents - pharmacology (2569) 2569
cell cycle proteins - metabolism (2530) 2530
activation (2469) 2469
chemotherapy (2465) 2465
analysis (2463) 2463
signal transduction (2375) 2375
kinases (2322) 2322
gene expression (2212) 2212
cell proliferation (2180) 2180
mitosis (2106) 2106
care and treatment (2010) 2010
mutation (1998) 1998
protein-serine-threonine kinases - metabolism (1938) 1938
melanoma (1921) 1921
metastasis (1869) 1869
genetic aspects (1853) 1853
p53 (1792) 1792
cancer therapies (1752) 1752
dna repair (1741) 1741
immunology (1674) 1674
genetics & heredity (1666) 1666
biology (1662) 1662
health aspects (1640) 1640
dna (1636) 1636
multidisciplinary sciences (1633) 1633
pharmacology & pharmacy (1606) 1606
cells (1595) 1595
dna-damage (1584) 1584
tumor suppressor protein p53 - metabolism (1569) 1569
inhibition (1548) 1548
signal transduction - drug effects (1547) 1547
nivolumab (1531) 1531
research article (1498) 1498
cell cycle checkpoints (1497) 1497
cell cycle proteins - genetics (1485) 1485
cytotoxicity (1451) 1451
hela cells (1447) 1447
deoxyribonucleic acid--dna (1443) 1443
protein (1394) 1394
rna interference (1389) 1389
cell line (1385) 1385
growth (1380) 1380
cell survival - drug effects (1376) 1376
proliferation (1374) 1374
lung cancer (1368) 1368
therapy (1365) 1365
cell death (1364) 1364
lymphocytes (1352) 1352
physiological aspects (1288) 1288
protein kinases - metabolism (1282) 1282
patients (1281) 1281
breast cancer (1264) 1264
medicine (1258) 1258
checkpoint kinase 1 (1247) 1247
flow cytometry (1235) 1235
middle aged (1229) 1229
immune checkpoint inhibitors (1190) 1190
saccharomyces-cerevisiae (1182) 1182
survival (1153) 1153
in-vitro (1147) 1147
xenograft model antitumor assays (1143) 1143
cell growth (1142) 1142
dose-response relationship, drug (1130) 1130
gene expression regulation, neoplastic (1127) 1127
cell-cycle (1125) 1125
medicine, research & experimental (1125) 1125
mice, nude (1102) 1102
dna replication (1096) 1096
lymphocytes t (1088) 1088
review (1083) 1083
ipilimumab (1074) 1074
pembrolizumab (1057) 1057
inhibitors (1042) 1042
protein binding (1037) 1037
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25497) 25497
German (118) 118
Japanese (102) 102
French (99) 99
Chinese (72) 72
Russian (15) 15
Korean (11) 11
Spanish (10) 10
Czech (8) 8
Polish (4) 4
Dutch (2) 2
Hungarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Cancer, ISSN 1474-175X, 01/2017, Volume 17, Issue 2, pp. 93 - 115
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 376, Issue 1, pp. 43 - 52
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 05/2017, Volume 77, Issue 10, pp. 2607 - 2619
Checkpoint inhibitors are relatively inefficacious in head and neck cancers, despite an abundance of genetic alterations and a T-cell-inflamed phenotype. One... 
HEAD | ACTIVATION | ONCOLOGY | IMMUNE-RESPONSES | REGULATORY T-CELLS | RESISTANCE | MECHANISMS | PI3K-GAMMA | EXPRESSION | CARCINOMA | NECK-CANCER | Neoplasms - metabolism | Immunomodulation - drug effects | Myeloid-Derived Suppressor Cells - drug effects | Lymphocyte Activation - immunology | Isoquinolines - pharmacology | Lymphocytes, Tumor-Infiltrating - metabolism | Antineoplastic Agents - pharmacology | Epitopes, T-Lymphocyte - immunology | Myeloid-Derived Suppressor Cells - metabolism | Disease Models, Animal | Myeloid-Derived Suppressor Cells - immunology | Purines - pharmacology | Antibodies, Monoclonal - pharmacology | Lymphocytes, Tumor-Infiltrating - drug effects | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Neoplasms - drug therapy | Tumor Microenvironment - immunology | Animals | B7-H1 Antigen - antagonists & inhibitors | Lymphocyte Activation - drug effects | Neoplasms - immunology | Survival Analysis | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Cell culture | Myeloid cells | Effectiveness | Cell survival | CD8 antigen | Effector cells | Lymphocytes T | Inflammation | Suppressor cells | Recruitment | Immunosuppression | Inhibitors | Immune checkpoint | Lymphocytes | PD-L1 protein | Isoforms | Head and neck | Head & neck cancer | Inhibition | Cancer | Immune system | immunosuppression | MDSC | IPI-145 | PI3K | head and neck cancer
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 06/2018, Volume 38, Issue 6, pp. 1063 - 1078
Purpose: To review immune checkpoint inhibitor indications and ophthalmic side effects. Methods: A literature review was performed using a PubMed search for... 
UROTHELIAL CARCINOMA | melanoma | OPEN-LABEL | uveitis | PEMBROLIZUMAB-INDUCED UVEITIS | SINGLE-ARM | eye | CELL LUNG-CANCER | pembrolizumab | METASTATIC UVEAL MELANOMA | inflammation | tumor | immunotherapy | ipilimumab | OPHTHALMOLOGY | orbit | MYASTHENIA-GRAVIS | BILATERAL UVEITIS | NIVOLUMAB PLUS IPILIMUMAB | ADVERSE EVENTS | checkpoint inhibitor
Journal Article
Journal Article